{"disease":{"id":"intermediate-risk-prostate-cancer","name":"intermediate risk prostate cancer"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07343349","title":"Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions","phase":"NA","overall_status":"RECRUITING","enrollment_count":1016,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT03340272","title":"PROspective Multicenter Observational Study on Elective Pelvic Nodes Irradiation.","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia","has_results":false},{"nct_id":"NCT07455097","title":"COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Heinrich-Heine University, Duesseldorf","has_results":false},{"nct_id":"NCT03650595","title":"MRI Guided Focal Laser Ablation of Prostate Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":102,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT06117059","title":"The PRECISION Study: 3 Fractions of Prostate SBRT and RayPilot HypoCath Image Guidance","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"NHS Lothian","has_results":false},{"nct_id":"NCT03815942","title":"VAccination in Early and ADvanced Prostate caNCEr","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":23,"lead_sponsor_name":"University of Oxford","has_results":true},{"nct_id":"NCT05917860","title":"Neoadjuvant ADT with TULSA in the Treatment of Intermediate Risk Prostate Cancer","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Turku University Hospital","has_results":false},{"nct_id":"NCT07339943","title":"Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness","phase":"NA","overall_status":"RECRUITING","enrollment_count":7,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT03740191","title":"Spot-Scanning Based Hypofractionated Proton Therapy for Low and Intermediate Risk Prostate Cancer","phase":"NA","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"EBG MedAustron GmbH","has_results":false},{"nct_id":"NCT05826470","title":"Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging","phase":"NA","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Genesis Research LLC","has_results":false},{"nct_id":"NCT03935308","title":"Phase I Study MR-guided SBRT to PCa","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Henry Ford Health System","has_results":false}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}